Monte Rosa Therapeutics (GLUE) Quarterly Loss Tests Bullish Profitability Narrative

CRISPR Therapeutics (CRSP) Is Down 5.1% After $550M Convertible Notes Offering - Has The Bull Case Changed?

Dow Jones Futures Rise As Oil Prices Fall; Fed Decision, Micron Earnings Loom

Is the Stock Market Due to Crash in 2026?

HELO: Working As Designed (NYSEARCA:HELO)

S&P 500 deliver surprising rebound from Iran conflict chaos